CytoDyn (OTCMKTS:CYDY) President and CEO Nader Pourhassan and Chairman and Chief Medical Officer Dr Richard Pestell joined Proactive Investors' Steve Darling during the 9th Annual LD Micro Invitational Investor Conference in Los Angeles, CA. Both talked about the company and where they are in the research on HIV and Triple Negative Breast Cancer.
CytoDyn shows value of company lies in their research and technology
Quick facts: CytoDyn Inc.
Price: 1.37 USD
Market Cap: $590.14 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of CytoDyn Inc. named herein, including the promotion by the Company of CytoDyn Inc. in any Content on the Site, the Company receives from said...FOR OUR FULL DISCLAIMER CLICK HERE